BioAegis Therapeutics

Morristown, United States

BioAegis is developing therapeutics for infectious, inflammatory and degenerative diseases based on the platform of plasma gelsolin.

$22.0M raised

Mar 2022

Venture - Series Unknown

Biotechnology Clinical Trials Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BioAegis Therapeutics

How much funding has BioAegis Therapeutics raised?

BioAegis Therapeutics has raised $22.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2022.

Where is BioAegis Therapeutics headquartered?

BioAegis Therapeutics is headquartered in Morristown, United States.

What does BioAegis Therapeutics do?

BioAegis is developing therapeutics for infectious, inflammatory and degenerative diseases based on the platform of plasma gelsolin.

What stage is BioAegis Therapeutics at?

BioAegis Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 22, 2022.

MLA

"BioAegis Therapeutics — Funding & Investors." VCBacked, March 22, 2022, https://www.vcbacked.co/company/bioaegis-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). BioAegis Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bioaegis-therapeutics

Wikipedia (cite web)

{{cite web |title=BioAegis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bioaegis-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 22, 2022.